CRP and Alzheimer disease: A commonly observed feature in both AD and frailty is the chronically low-grade elevation in pro-inflammatory markers such as interleukin-6 (IL-6), interleukin-1β (IL-1β), C-reactive protein (CRP), and tumor necrosis factor alpha (TNF⍺) [5–7].